(Q51497817)

English

Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.

scientific article published in June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

1 reference

based on heuristic

inferred from title

Marie-Hélène Gannagé-Yared

1

object named as

Marie-Hélène Gannagé-Yared

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

author name string

Florence Fares

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

Michelle Semaan

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

Simon Khalife

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

Selim Jambart

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

64

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

652-658

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Adipocytokines and insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Correlates of osteoprotegerin levels in women and men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Serum osteoprotegerin in adolescent girls with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Adiponectin and protection against type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Increased osteoprotegerin serum levels in men with coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02522.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2006.02522.X

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16712667

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51497817&oldid=1364884193"